These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 3705836)
1. [Use of therapeutic plasmapheresis in patients with generalized myasthenia during exacerbations in the late period following thymectomy]. Marchuk AI; Golovteev VV; Sapin SM; Shagal DI Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):330-3. PubMed ID: 3705836 [TBL] [Abstract][Full Text] [Related]
2. [Splenectomy in the treatment of severe generalized myasthenia gravis (first experience)]. Kuzin MI; Shkrob OS; Gekht BM; Vetshev PS; Shagal DI; Zaĭrat'iants OV; Khodzhaev ZSh; Ippolitov IKh Khirurgiia (Mosk); 1990 Aug; (8):95-9. PubMed ID: 2259184 [TBL] [Abstract][Full Text] [Related]
3. [Plasmapheresis in combined treatment of severe generalized myasthenia]. Vetshev PS; Shkrob OS; Sanadze AG; Khodzhaev ZSh; Ippolitov IKh; Chilingaridi KE; Vanushko VE Khirurgiia (Mosk); 1991 Apr; (4):95-102. PubMed ID: 2062079 [TBL] [Abstract][Full Text] [Related]
4. Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis--a comparative study. Sarkar BK; Sengupta P; Sarkar UN Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1007-10. PubMed ID: 18682429 [TBL] [Abstract][Full Text] [Related]
6. [Usefulness of plasmapheresis before thymectomy in the management of myasthenia gravis]. Iváñez V; Díez-Tejedor E; Lara M; Barreiro P Neurologia; 1994; 9(7):277-81. PubMed ID: 7946422 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic options in autoimmune myasthenia gravis. García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383 [TBL] [Abstract][Full Text] [Related]
8. [Intensive care in myasthenic and cholinergic crises]. Popova LM; Piradov MA Anesteziol Reanimatol; 1996; (2):13-5. PubMed ID: 8754165 [TBL] [Abstract][Full Text] [Related]
12. [Features of the clinical picture, course and treatment of myasthenia in late middle-aged and aged persons]. Gladyshev SS; Gekht BM; Kolomenskaia EA Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1633-8. PubMed ID: 3811723 [TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis: effect of immunoactive therapies. Fornádi L; Horváth R; Bárdosi Z; Szobor A Acta Med Hung; 1994; 50(1-2):83-92. PubMed ID: 7638045 [TBL] [Abstract][Full Text] [Related]
14. Clinical spectrum of myasthenia gravis and problems of management. Dhamija RM; Venkataraman S; Roy AK; Sanchetee PC; Bhargava AK J Assoc Physicians India; 1991 Feb; 39(2):181. PubMed ID: 1885481 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the results of different therapeutic measures in 198 myasthenia gravis patients. Apostolski S; Lavrnić D; Djukić P; Trikić R; Gospavić J; Dotlić R; Pavlović S Monogr Allergy; 1988; 25():86-95. PubMed ID: 3173364 [No Abstract] [Full Text] [Related]